A company's organizational evolution and portfolio lifecycle stages influence how corporate brands, functions, groups and companies grow, succeed, stumble or fail. Benchmark studies across therapeutic areas, global regions, functional areas and product lifecycles reveal similar insights.
This document is a presentation by Chris Bogan, Best Practices, LLC chief executive, that uses client case studies to illustrate how a company's size and lifecycle stage influence its strategic approach to the market. By understanding the lifecycle stage of your organization, group or brand, a company can forecast and proactively respond to issues that lie ahead. This presentation contains performance benchmarks from Best Practices, LLC research that highlight factors that can inform executives whose organizations are facing internal and external change.
SAMPLE KEY METRICS
Does your company have an engagement strategy for CMS?
Location of U.S. Policy group staff
Risk level for various physician pitfall factors
Development phase when in-line commercial group assumes control of therapy
Primary department where analytics activties are performed
Role of Market Research function in your company
Annual number of Market Research projects conducted
SAMPLE KEY FINDINGS
Many Windows To The Performance World: Benchmarking is a flexible tool that permits +25
perspectives by which to study your group’s performance, evolution and impact.
Fate Maps & Life Paths Can Be Predictive: Brands and organizations follow predictable life
paths or fate maps. By understanding the lifecycle stage of your organization, group or brand,
you can forecast and proactively respond to issues that lie ahead.